SCHEMBL16503520

SCHEMBL16503520

COC(=O)/C=C/CC(/C=C/c1ccccc1)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
BACE1 P56817 1/20 0.38
EGFR P00533 1/20 0.36
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
NR1H4 Q96RI1 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16503524 0.79 POLB (0.35) KMT2ABACE1KDM4ESMN1; SMN2RAB9A
SCHEMBL16503530 0.79 RECQL (0.34) KMT2AMEN1BACE1KDM4ESMN1; SMN2
SCHEMBL4135244 0.76 HDAC3 (0.38) BACE1EGFRKDM4EHDAC3HDAC4
SCHEMBL4135249 0.76 HDAC3 (0.38) BACE1EGFRKDM4EHDAC3HDAC4
SCHEMBL437879 0.75 MEN1 (0.48) KMT2AMEN1BACE1CYP1A2
SCHEMBL16503516 0.74 TSHR (0.40) KMT2AMEN1BACE1CYP1A2
SCHEMBL7724626 0.72 CYP1A2 (0.44) KMT2AMEN1BACE1EGFRSMN1; SMN2
SCHEMBL7724629 0.72 CYP1A2 (0.44) KMT2AMEN1BACE1EGFRSMN1; SMN2
SCHEMBL16503521 0.72 POLB (0.33) KMT2AMEN1KDM4ENR1H4ALDH1A1
SCHEMBL16503532 0.71 CCNC (0.38) KMT2AMEN1KDM4ESMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403842-B1 CHIRAL DISULFONIMIDES STUDIENGESELLSCHAFT KOHLE MBH (DE) 2016-06-29 EP disclosed
US-9079869-B2 Chiral disulfonimides STUDIENGESELLSCHAFT KOHLE MBH (DE) 2015-07-14 US disclosed
US-9079869-B2 Chiral disulfonimides STUDIENGESELLSCHAFT KOHLE MBH (DE) 2015-07-14 US disclosed
US-20110313150-A1 CHIRAL DISULFONIMIDES STUDIENGESELLSCHAFT KOHLE MBH (DE) 2011-12-22 US disclosed
US-20110313150-A1 CHIRAL DISULFONIMIDES STUDIENGESELLSCHAFT KOHLE MBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313150-A1 CHIRAL DISULFONIMIDES STS, SUDS3, SF1 KMT2A 3397/4885MEN1 1578/4885BACE1 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.